{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:38:08Z","timestamp":1775705888476,"version":"3.50.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.suc.2008.05.001","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T04:24:37Z","timestamp":1217391877000},"page":"863-895","source":"Crossref","is-referenced-by-count":73,"title":["Multiple Endocrine Neoplasia Syndromes"],"prefix":"10.1016","volume":"88","author":[{"given":"Glenda G.","family":"Callender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thereasa A.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2008.05.001_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1196\/annals.1294.020","article-title":"Molecular pathology of the MEN1 gene","volume":"1014","author":"Agarwal","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.suc.2008.05.001_bib2","series-title":"World Health Organization Classification of Tumours","article-title":"Pathology and genetics: Tumours of the endocrine organs","author":"DeLellis","year":"2004"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/301729","article-title":"Characterization of mutations in patients with multiple endocrine neoplasia type 1","volume":"62","author":"Bassett","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.suc.2008.05.001_bib4","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.85.12.4776","article-title":"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.suc.2008.05.001_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.suc.2008.05.001_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000061047","article-title":"Clinical and molecular aspects of multiple endocrine neoplasia type 1","volume":"28","author":"Chandrasekharappa","year":"2001","journal-title":"Front Horm Res"},{"key":"10.1016\/j.suc.2008.05.001_bib7","series-title":"The metabolic and molecular basis of inherited disease, 8","first-page":"943","article-title":"Multiple endocrine neoplasia type 1","author":"Marx","year":"2001"},{"issue":"10","key":"10.1016\/j.suc.2008.05.001_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2265.2000.00966.x","article-title":"Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1","volume":"52","author":"Hai","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.suc.2008.05.001_bib10","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.suc.2008.05.001_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.sla.0000124383.98416.8d","article-title":"Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1)","volume":"239","author":"Lairmore","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2008.05.001_bib12","unstructured":"Clark O, Ajani J, Benson A. Neuroendocrine tumors, in NCCN oncology practice guidelines v.1.2007. Available at: www.nccn.org. Last accessed February, 2008."},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0039-6060(98)70040-6","article-title":"Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1","volume":"124","author":"Hellman","year":"1998","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","article-title":"Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"134","author":"Elaraj","year":"2003","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1067\/msy.2001.118379","article-title":"Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1","volume":"130","author":"Kivlen","year":"2001","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","article-title":"Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"140","author":"Lambert","year":"2005","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/msy.1998.93107","article-title":"The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1","volume":"124","author":"Carty","year":"1998","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jc.87.2.457","article-title":"Pituitary disease in MEN type 1 (MEN1): data from\u00a0the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib19","first-page":"475","article-title":"The MEA-I syndrome: an all or none phenomenon?","volume":"86","author":"Majewski","year":"1979","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002689900438","article-title":"Lethality of multiple endocrine neoplasia type\u00a0I","volume":"22","author":"Doherty","year":"1998","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.suc.2008.05.001_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199908263410902","article-title":"Surgery to cure the Zollinger-Ellison syndrome","volume":"341","author":"Norton","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/edrv-8-4-391","article-title":"Familial multiple endocrine neoplasia type I: a new look at pathophysiology","volume":"8","author":"Brandi","year":"1987","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib25","first-page":"958","article-title":"Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study","volume":"102","author":"Norton","year":"1987","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.suc.2008.05.001_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s002689900133","article-title":"Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I","volume":"20","author":"Skogseid","year":"1996","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2796.1998.00307.x","article-title":"Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both","volume":"243","author":"Thompson","year":"1998","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/msy.2000.109727","article-title":"Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?","volume":"128","author":"Bartsch","year":"2000","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00000658-200006000-00016","article-title":"Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1","volume":"231","author":"Lairmore","year":"2000","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00000658-199201000-00012","article-title":"Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study","volume":"215","author":"Norton","year":"1992","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2796.1998.00281.x","article-title":"Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1","volume":"243","author":"Jensen","year":"1998","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000658-200110000-00009","article-title":"Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome","volume":"234","author":"Norton","year":"2001","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib33","first-page":"998","article-title":"Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach","volume":"110","author":"Demeure","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.suc.2008.05.001_bib34","series-title":"Pancreatic cancer","first-page":"631","article-title":"Multiple endocrine neoplasia type 1","author":"Kouvaraki","year":"2005"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0889-8529(05)70150-X","article-title":"Multiple endocrine neoplasia type 1","volume":"29","author":"Thakker","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF01655108","article-title":"Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I","volume":"17","author":"Mignon","year":"1993","journal-title":"World J\u00a0Surg"},{"key":"10.1016\/j.suc.2008.05.001_bib37","series-title":"Advanced therapy in surgical oncology","first-page":"449","article-title":"The surgical treatment of MEN-1","author":"Kouvaraki","year":"2008"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","article-title":"Thymic carcinoids in multiple endocrine neoplasia type\u00a01","volume":"228","author":"Teh","year":"1998","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening","volume":"392","author":"Waldmann","year":"2007","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1098-2264(199909)26:1<35::AID-GCC5>3.0.CO;2-L","article-title":"Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene","volume":"26","author":"Nord","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1016\/j.suc.2008.05.001_bib41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.133.7.853","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib42","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1","volume":"89","author":"Asgharian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)61788-9","article-title":"Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1","volume":"159","author":"McKeeby","year":"2001","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.suc.2008.05.001_bib44","first-page":"919","article-title":"Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors","volume":"12","author":"Vortmeyer","year":"1999","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","article-title":"Meningiomas may be a component tumor of multiple endocrine neoplasia type 1","volume":"10","author":"Asgharian","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib46","first-page":"444","article-title":"Clinicogenetic study of MEN1: recent physiopathological data and clinical applications. Study Group of Multiple Endocrine Neoplasia (GENEM)","volume":"59","author":"Calender","year":"1998","journal-title":"Ann Endocrinol (Paris)"},{"issue":"23","key":"10.1016\/j.suc.2008.05.001_bib47","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1007\/s00018-004-4276-8","article-title":"Dysfunction of the RET receptor in human cancer","volume":"61","author":"Santoro","year":"2004","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.suc.2008.05.001_bib48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/BF03345322","article-title":"Exon 5 of the RET proto-oncogene: a newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg","volume":"28","author":"Dvorakova","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib49","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1210\/jc.2003-030997","article-title":"A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma","volume":"88","author":"Da Silva","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.suc.2008.05.001_bib50","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.276.19.1575","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.suc.2008.05.001_bib51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199409293311302","article-title":"Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A","volume":"331","author":"Lips","year":"1994","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.suc.2008.05.001_bib52","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":"Early malignant progression of hereditary medullary thyroid cancer","volume":"349","author":"Machens","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib53","first-page":"1017","article-title":"Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B","volume":"116","author":"O'Riordain","year":"1994","journal-title":"Surgery"},{"issue":"8582","key":"10.1016\/j.suc.2008.05.001_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(88)91191-9","article-title":"Risk estimation and screening in families of patients with medullary thyroid carcinoma","volume":"1","author":"Ponder","year":"1988","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib55","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/3.11.1939","article-title":"RET proto-oncogene mutations in French MEN 2A and FMTC families","volume":"3","author":"Schuffenecker","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0194-70","article-title":"Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC","volume":"6","author":"Mulligan","year":"1994","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.83.3.770","article-title":"A new hot spot for mutations in the RET protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A","volume":"83","author":"Berndt","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.suc.2008.05.001_bib58","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/hmg\/3.12.2163","article-title":"Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene","volume":"3","author":"Mulligan","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM196807042790101","article-title":"Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. A possible regulatory defect in the differentiation of chromaffin tissue","volume":"279","author":"Schimke","year":"1968","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1245\/s10434-007-9665-4","article-title":"Failure to recognize multiple endocrine neoplasia 2B: more common than we think?","volume":"15","author":"Wray","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","article-title":"Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium","volume":"238","author":"Mulligan","year":"1995","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib62","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jc.82.11.3902","article-title":"Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation","volume":"82","author":"Gimm","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.suc.2008.05.001_bib63","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000658-200211000-00006","article-title":"Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790\/791 germline mutations","volume":"236","author":"Fitze","year":"2002","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib64","first-page":"39","article-title":"Germline V804M mutation in the RET proto-oncogene in two apparently sporadic cases of MTC presenting in the seventh decade of life","volume":"1","author":"Shannon","year":"1999","journal-title":"J Endocr Genet"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib65","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/msy.2002.128559","article-title":"RET proto-oncogene mutations affecting codon 790\/791: a mild form of multiple endocrine neoplasia type 2A syndrome?","volume":"132","author":"Gimm","year":"2002","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.suc.2008.05.001_bib66","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00268-004-7640-9","article-title":"Timing and extent of surgery in patients with familial medullary thyroid carcinoma\/multiple endocrine neoplasia 2A\u2013related RET mutations not affecting codon 634","volume":"28","author":"Gimm","year":"2004","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib67","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/1097-0142(20000815)89:4<863::AID-CNCR19>3.0.CO;2-Z","article-title":"Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?","volume":"89","author":"Hansen","year":"2000","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.suc.2008.05.001_bib68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/105072502320288393","article-title":"Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation","volume":"12","author":"Brauckhoff","year":"2002","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.suc.2008.05.001_bib69","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2007-1005","article-title":"RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center","volume":"92","author":"Elisei","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib70","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2004.01423.x","article-title":"Advances in the management of hereditary medullary thyroid cancer","volume":"257","author":"Machens","year":"2005","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/archsurg.1980.01380020012004","article-title":"Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications","volume":"115","author":"Block","year":"1980","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib72","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2796.2003.01166.x","article-title":"Surgical treatment of medullary thyroid carcinoma","volume":"253","author":"Cohen","year":"2003","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-115-2-133","article-title":"Thyroid cancer: a lethal endocrine neoplasm","volume":"115","author":"Robbins","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.suc.2008.05.001_bib74","series-title":"Advanced therapy in surgical oncology","first-page":"465","article-title":"Surgical treatment of multiple endocrine neoplasia type 2 (MEN-2)","author":"Kouvaraki","year":"2008"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib75","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: Which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib76","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.suc.2008.05.001_bib77","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib78","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/msy.2000.110846","article-title":"Pheochromocytoma: inherited associations, bilaterality, and cortex preservation","volume":"128","author":"Inabnet","year":"2000","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib79","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jamcollsurg.2003.12.001","article-title":"Surgical management of hereditary pheochromocytoma","volume":"198","author":"Yip","year":"2004","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.suc.2008.05.001_bib81","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-0476","article-title":"Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases","volume":"92","author":"Tham","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib82","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2005.02190.x","article-title":"Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing","volume":"62","author":"Ellard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/jmg.2003.017319","article-title":"A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing","volume":"42","author":"Cardinal","year":"2005","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","article-title":"Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications","volume":"41","author":"Warner","year":"2004","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib85","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2265.2006.02438.x","article-title":"Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management","volume":"64","author":"Cetani","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib86","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/jmg.2005.035766","article-title":"Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14","volume":"43","author":"Warner","year":"2006","journal-title":"J Med Genet"},{"issue":"5454","key":"10.1016\/j.suc.2008.05.001_bib87","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib88","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib89","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"19","key":"10.1016\/j.suc.2008.05.001_bib90","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.suc.2008.05.001_bib91","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.86.5.1999","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.suc.2008.05.001_bib92","first-page":"235","article-title":"Metastatic carotid body paraganglioma in von Hippel-Lindau disease. An electron microscopic study","volume":"106","author":"Hull","year":"1982","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib93","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jama.275.11.839","article-title":"Von Hippel-Lindau disease and pheochromocytoma","volume":"275","author":"Walther","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib95","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2265.2006.02714.x","article-title":"Phaeochromocytoma, new genes and screening strategies","volume":"65","author":"Gimenez-Roqueplo","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib96","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.suc.2008.05.001_bib97","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib98","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.suc.2008.05.001_bib99","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.294.16.2057","article-title":"Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene","volume":"294","author":"Schiavi","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.suc.2008.05.001_bib100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","article-title":"Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B\u2013associated pheochromocytomas and paragangliomas","volume":"92","author":"Timmers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajmg.c.30018","article-title":"Genomic imprinting and environment in hereditary paraganglioma","volume":"129","author":"Baysal","year":"2004","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.278.1.51","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","author":"Gutmann","year":"1997","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.suc.2008.05.001_bib103","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.otohns.2007.01.015","article-title":"Malignant head and neck paragangliomas in SDHB mutation carriers","volume":"137","author":"Boedeker","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.suc.2008.05.001_bib104","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the real Cowden syndrome please stand up: revised diagnostic criteria","volume":"37","author":"Eng","year":"2000","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.suc.2008.05.001_bib105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s002689900462","article-title":"Thyroid cancer in patients with familial adenomatous polyposis","volume":"22","author":"Perrier","year":"1998","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.suc.2008.05.001_bib106","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.suc.2008.05.001_bib107","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/302164","article-title":"A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2","volume":"63","author":"Canzian","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.suc.2008.05.001_bib108","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/321979","article-title":"Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21","volume":"69","author":"McKay","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.suc.2008.05.001_bib109","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1210\/jc.85.5.1758","article-title":"Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome","volume":"85","author":"Malchoff","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.suc.2008.05.001_bib110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/thy.1998.8.857","article-title":"On the prevalence of familial nonmedullary thyroid cancer","volume":"8","author":"Charkes","year":"1998","journal-title":"Thyroid"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610908000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610908000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T17:55:19Z","timestamp":1545846919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610908000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0039610908000704"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2008.05.001","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}